AtriCure, Inc. (ATRC) Balance Sheet

Accumulated deficit widened from -$378.3M to -$400.1M over the same span, which implies that equity expansion is coming from paid-in capital rather than retained earnings. This suggests the balance sheet strength depends on external capital and ongoing equity access rather than internally generated profits. Investors should monitor whether asset growth continues to outpace liabilities as the company works toward sustained GAAP profitability.

A debt-to-equity ratio in the mid-teens suggests the company is not dependent on borrowing to fund operations, which reduces refinancing and interest-rate risk. The relatively stable debt level across ten quarters implies a deliberate, non-expanding capital structure rather than a necessity-driven borrowing pattern. Cash flow durability, rather than debt service capacity, appears to be the more relevant constraint to monitor.

A current ratio above 4 and cash rising from $99.9M in Q1 2025 to $187.0M suggests the company has built a meaningful cushion against working capital swings. The recurring first-quarter cash dips alongside working capital outflows imply a seasonal pattern that the buffer appears to absorb. Liquidity looks adequate near term, though its sufficiency depends on continued progress toward self-funded operations.

Goodwill accounts for roughly a third to two-fifths of total assets, indicating that a significant portion of the balance sheet reflects acquired value rather than tangible production capacity. Net PPE of $46M to $72M is modest, consistent with an asset-light operating model. Persistent operating losses raise the question of impairment risk if acquired businesses underperform, and investors should monitor goodwill levels against future earnings recovery.